BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology
GlobeNewswire
RESEARCH TRIANGLE PARK, N.C., May 14, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals Inc. (Nasdaq: BCRX) today announced that..